Jakuš Vladimír, Sapák Michal, Kostolanská Jana
Institute of Medical Chemistry, Biochemistry and Clinical Biochemistry, Faculty of Medicine, Comenius University, Sasinkova 2, Bratislava 81108, Slovakia.
Exp Diabetes Res. 2012;2012:510902. doi: 10.1155/2012/510902. Epub 2012 Sep 26.
The present study investigates the relationship between diabetes metabolic control represented by levels of HbA1c, early glycation products-(fructosamine (FAM)), serum-advanced glycation end products (s-AGEs), lipoperoxidation products (LPO), advanced oxidation protein products (AOPP) and circulating TGF-β in young patients with DM1. The study group consisted of 79 patients with DM1 (8-18 years). 31 healthy children were used as control (1-16 years). Baseline characteristics of patients were compared by Student's t-test and nonparametric Mann-Whitney test (Statdirect), respectively. The correlations between the measured parameters were examined using Pearson correlation coefficient r and Spearman's rank test, respectively. A P value < 0.05 was considered as statistically significant. HbA1c was measured by LPLC, s-AGEs spectrofluorimetrically, LPO and AOPP spectrophotometrically and TGF-β by ELISA. Our results showed that parameters of glycation and oxidation are significantly higher in patients with DM1 than in healthy control. The level of serum TGF-β was significantly higher in diabetics in comparison with control: 7.1(3.6; 12.6) versus 1.6(0.8; 3.9) ng/mL. TGF-β significantly correlated with age and duration of DM1. There was not found any significant relation between TGF-β and parameres of glycation and oxidation. However, these results do not exclude the association between TGF-β and the onset of diabetic complications.
本研究调查了1型糖尿病(DM1)年轻患者中,以糖化血红蛋白(HbA1c)水平、早期糖化产物(果糖胺(FAM))、血清晚期糖基化终产物(s-AGEs)、脂质过氧化产物(LPO)、晚期氧化蛋白产物(AOPP)以及循环转化生长因子-β(TGF-β)为代表的糖尿病代谢控制之间的关系。研究组由79例DM1患者(8至18岁)组成。31名健康儿童作为对照(1至16岁)。分别采用学生t检验和非参数曼-惠特尼检验(Statdirect)比较患者的基线特征。分别使用皮尔逊相关系数r和斯皮尔曼秩检验来检验所测参数之间的相关性。P值<0.05被认为具有统计学意义。HbA1c采用液相色谱法测定,s-AGEs采用荧光分光光度法测定,LPO和AOPP采用分光光度法测定,TGF-β采用酶联免疫吸附测定法(ELISA)测定。我们的结果表明,DM1患者的糖化和氧化参数显著高于健康对照。糖尿病患者血清TGF-β水平显著高于对照组:7.1(3.6;12.6)对1.6(0.8;3.9)ng/mL。TGF-β与DM1的年龄和病程显著相关。未发现TGF-β与糖化和氧化参数之间存在任何显著关系。然而,这些结果并不排除TGF-β与糖尿病并发症发病之间的关联。